Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
Sponsor: Priovant Therapeutics, Inc.
Summary
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.
Official title: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Cutaneous Sarcoidosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
168
Start Date
2025-04-09
Completion Date
2029-12-31
Last Updated
2026-11-03
Healthy Volunteers
No
Conditions
Interventions
Oral Brepocitinib
Oral Brepocitinib
Oral Placebo
Placebo
Locations (44)
Clinical Trial Site
Birmingham, Alabama, United States
Clinical Trial Site
Phoenix, Arizona, United States
Clinical Trial Site
Tucson, Arizona, United States
Clinical Trial Site
San Francisco, California, United States
Clinical Trial Site
New Haven, Connecticut, United States
Clinical Trial Site
Washington D.C., District of Columbia, United States
Clinical Trial Site
Atlanta, Georgia, United States
Clinical Trial Site
Sandy Springs, Georgia, United States
Clinical Trial Site
Chicago, Illinois, United States
Clinical Trial Site
Chicago, Illinois, United States
Clinical Trial Site
Kansas City, Kansas, United States
Clinical Trial Site
Louisville, Kentucky, United States
Clinical Trial Site
New Orleans, Louisiana, United States
Clinical Trial Site
Baltimore, Maryland, United States
Clinical Trial Site
Boston, Massachusetts, United States
Clinical Trial Site
Ann Arbor, Michigan, United States
Clinical Trial Site
Ann Arbor, Michigan, United States
Clinical Trial Site
Troy, Michigan, United States
Clinical Trial Site
St Louis, Missouri, United States
Clinical Trial Site
Lebanon, New Hampshire, United States
Clinical Trial Site
Brooklyn, New York, United States
Clinical Trial Site
Lake Success, New York, United States
Clinical Trial Site
New York, New York, United States
Clinical Trial Site
New York, New York, United States
Clinical Trial Site
Rochester, New York, United States
Clinical Trial Site
Chapel Hill, North Carolina, United States
Clinical Trial Site
Durham, North Carolina, United States
Clinical Trial Site
Greenville, North Carolina, United States
Clinical Trial Site
Cleveland, Ohio, United States
Clinical Trial Site
Fairborn, Ohio, United States
Clinical Trial Site
Hershey, Pennsylvania, United States
Clinical Trial Site
Philadelphia, Pennsylvania, United States
Clinical Trial Site
Philadelphia, Pennsylvania, United States
Clinical Trial Site
Charleston, South Carolina, United States
Clinical Trial Site
Houston, Texas, United States
Clinical Trial Site
Norfolk, Virginia, United States
Clinical Trial Site
Richmond, Virginia, United States
Clinical Trial Site
Madison, Wisconsin, United States
Clinical Trial Site
Milwaukee, Wisconsin, United States
Clinical Trial Site
Melbourne, Victoria, Australia
Clinical Trial Site
Parkville, Victoria, Australia
Clinical Trial Site
Coventry, United Kingdom
Clinical Trial Site
London, United Kingdom
Clinical Trial Site
Manchester, United Kingdom